3. Sharif A. Preventing and managing hyperglycemia in kidney transplant patients. Curr Opin Nephrol Hypertens 2012;21:574–579.
4. Jin J, Jin L, Luo K, Lim SW, Chung BH, Yang CW. Effect of empagliflozin on tacrolimus-induced pancreas islet dysfunction and renal injury. Am J Transplant 2017;17:26012616.
6. Lenaz G, Fato R, Formiggini G, Genova ML. The role of Coenzyme Q in mitochondrial electron transport. Mitochondrion 2007;7 Suppl:S8–S33.
7. Negida A, Menshawy A, El Ashal G, et al. Coenzyme Q10 for patients with Parkinson’s disease: a systematic review and meta-analysis. CNS Neurol Disord Drug Targets 2016;15:45–53.
9. Ozcan P, Fiçicioglu C, Kizilkale O, et al. Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage? J Assist Reprod Genet 2016;33:12231230.
10. Prangthip P, Kettawan A, Posuwan J, Okuno M, Okamoto T. An improvement of oxidative stress in diabetic rats by ubiquinone-10 and ubiquinol-10 and bioavailability after short- and long-term Coenzyme Q10 supplementation. J Diet Suppl 2016;13:647–659.
12. Xue R, Yang J, Wu J, Meng Q, Hao J. Coenzyme Q10 inhibits the activation of pancreatic stellate cells through PI3K/ AKT/mTOR signaling pathway. Oncotarget 2017;8:9230092311.
14. Bauerova K, Paulovicova E, Mihalova D, et al. Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress. Acta Biochim Pol 2010;57:347–354.
15. Hwang H, Ghee JY, Song JH, Piao S, Yang CW. Comparison of adverse drug reaction profiles of two tacrolimus formulations in rats. Immunopharmacol Immunotoxicol 2012;34:434–442.
16. Visconti GL, Mazzoleni L, Rusconi C, et al. Determination by UPLC/MS-MS of Coenzyme Q10 (CoQ10) in plasma of healthy volunteers before and after oral intake of food supplements containing CoQ10. J Anal Bioanal Tech 2015;S13:011.
20. Borowy-Borowski H, Sodja C, Docherty J, Walker PR, Sikorska M. Unique technology for solubilization and delivery of highly lipophilic bioactive molecules. J Drug Target 2004;12:415–424.
21. Liu ZX, Artmann C. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Altern Ther Health Med 2009;15:42–46.
22. Martinefski M, Samassa P, Buontempo F, Hocht C, Lucangioli S, Tripodi V. Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy. J Pharm Pharmacol 2017;69:567–573.
23. Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 2007;7 Suppl:S78–S88.
24. Lim SW, Jin L, Luo K, Jin J, Yang CW. Ginseng extract reduces tacrolimus-induced oxidative stress by modulating autophagy in pancreatic beta cells. Lab Invest 2017;97:12711281.
25. Jin L, Lim SW, Jin J, et al. Effect of conversion to CTLA4Ig on tacrolimus-induced diabetic rats. Transplantation 2018;102:e137–e146.
28. Smith RA, Adlam VJ, Blaikie FH, et al. Mitochondria-targeted antioxidants in the treatment of disease. Ann N Y Acad Sci 2008;1147:105–111.